The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention
Age: 18 years - 55 years
Patients receiving obstetrical-related care at a CUMC-affiliated enrollment site
Patients who have elected to undergo OCS with the CUMC-affiliated obstetrics provider
Patients with prior OCS but planned to repeat OCS are eligible
Patients who have previously completed a multigene hereditary cancer syndrome panel
Patients that have a hematologic cancer or hematologic pre-cancer
Patients who have a history of an autologous bone marrow transplant
Columbia University
Lead sponsor
Natera, Inc.
Collaborator